CSL LIMITED

CSL
Delayed Australian Stock Exchange - 12:10 2022-12-02 am EST
301.89 AUD +1.08%

Turn to zoom
Prev.301.89000000
Open300.95000000
High303.50000000
Low299.70000000
Volume880 741
Latest news
8h ago
2d ago
4d ago
4d ago
Chart CSL LIMITED
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance303303316
Spread/Res.-0,23%-0,23%-4,3%
Spread/Supp.6,6%9,5%8,5%
Support283276278
Financials
Sales 2023 13 129 M - -
Net income 2023 2 344 M - -
Net Debt 2023 10 272 M - -
P/E ratio 2023 43,0x
Yield 2023 1,16%
Capitalization 99 086 M 99 086 M -
EV / Sales 2023 8,33x
EV / Sales 2024 7,40x
Nbr of Employees 30 000
Free-Float 99,9%
Company
CSL Limited (CSL) is a biotechnology company engaged in developing and delivering biotherapies and influenza vaccines that treat people with serious diseases and chronic medical conditions. CSL provides a portfolio of life saving medicines, including those that treat hemophilia and immune...
Sector :
Biopharmaceuticals
Calendar :
2023-02-15 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 205,48 $
Average target price 211,10 $
Spread / Average Target 2,73%